HIF1A and metabolic dysfunction-associated steatotic liver disease: Glycyrrhetinic acid modulates the STAT3-HIF-1α pathway in macrophages, enhancing autophagy flux impairment. This mitigates the excessive generation of inflammatory cytokines and hepatocyte apoptosis, thereby alleviating the progression of NAFLD.